Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?
Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?
复制标题
DOI:
10.1136/jmg.40.5.e52
复制
发表时间:
2003-05-01
影响因子:
4
通讯作者:
Yamashita, Y
中科院分区:
文献类型:
--
作者:
Leonard, H;Colvin, L;Yamashita, Y
Australia. 1 It is characterised by apparently normal development between 6 and 18 months, followed by a period of regression with loss of purposeful hand use, deceleration of head growth, and onset of repetitive, stereotypic hand movements. 2 Affected people also manifest gait ataxia and apraxia, autistic features, epileptic seizures, respiratory dysfunction, autonomic dysfunction, and decreased somatic growth. 2 3 In recent years it has become apparent that the phenotypic range of this disorder is much wider than previously thought. Some patients may have a milder phenotype and retain the ability to walk or speak and others have an earlier onset and more severe features. People who have some but not all of the necessary criteria have been categorised as atypical4 or as one of six variant forms. 5 Rett syndrome has now been shown to be associated with mutations in the methyl-CpG-binding protein 2 (MeCP2). 6 For many genetic disorders, the next stage in research after the identification of the gene involves describing the relation between genotype and phenotype, and the phenotypic diversity produced by different mutations in the same gene. Some research has found that people with missense MECP2 mutations may have a milder phenotype than those with truncating mutations. 7 8 Weaving et al9 found that age at onset of hand stereotypies was later and speech and height (but not head growth) were slightly more normal in those with missense mutations whereas Nielsen et al10 found no difference in severity between these mutation types. In the study of Amir et al11 breathing abnormalities were found to be more common with truncating mutations and scoliosis more common with missense mutations. Hoffbuhr et al12 concluded that patients with missense mutations in the methyl binding domain (MBD) and mutations truncating the entire transcription repression domain (TRD) were more severely affected than those with missense and nonsense mutations in the TRD and C terminal segment. Similarly, in another study, a milder phenotype was associated with late compared with early truncating mutations. 13 In a recent publication, Huppke et al14 considered those mutations in the nuclear localisation signal (NLS) as a separate category from the other truncating mutations. Overall, they found that cases with mutations leading to a partial or complete truncation of the NLS were more severe than those with mutations downstream of the TRD. Although some phenotypic associations with different classes of mutations within MECP2 are emerging, the reports are hampered by relatively small sample size. In one recent review, it was actually suggested that a simple relation between clinical severity and type of mutation may not even exist. 15 The location of MECP2 on the X chromosome makes it very likely that altered patterns of X inactivation also contribute to the phenotypic variation as seen in heterozygous females from the same family. 16 The closeness of the correlation between skewed X inactivation patterns and the phenotype seen remains uncertain. In the two most comprehensive reported studies, Hoffbuhr et al12 found skewing (defined as> 85% of one X allele active) in 6/39 (15%) cases whereas Weaving et al9 with a more liberal definition (> 75% of one X allele active) found it in 31/72 (43%).Functional analysis of specific mutations associated with Rett syndrome is now also being undertaken. Similar to some other missense mutations in the MBD, the R133C mutation has been shown to abrogate methylation specific binding to the DNA template. 17 However, in a later study Kudo et al18 found the R133C mutant to be functionally almost …